Close
MyNorthwest
News
Opinion
Sports
Tools
Connect

Appeals court to consider paving way for Purdue Pharma deal

FILE - A man looks at cardboard gravestones with the names of victims of opioid abuse outside the courthouse where the Purdue Pharma bankruptcy is taking place in White Plains, N.Y., Monday, Aug. 9, 2021. A federal appeals panel is scheduled to hear arguments on whether members of the Sackler family can be granted protection from lawsuits as part of a bankruptcy settlement for the company they own, OxyContin maker Purdue Pharma. If the company doesn’t get what it wants, it could have to fight off thousands of individual lawsuits. (AP Photo/Seth Wenig) FILE - Jayde Newton helps to set up cardboard gravestones with the names of victims of opioid abuse outside the courthouse where the Purdue Pharma bankruptcy is taking place in White Plains, N.Y., on Aug. 9, 2021. A federal appeals panel is scheduled to hear arguments on whether members of the Sackler family can be granted protection from lawsuits as part of a bankruptcy settlement for the company they own, OxyContin maker Purdue Pharma. If the company doesn’t get what it wants, it could have to fight off thousands of individual lawsuits. (AP Photo/Seth Wenig, File) FILE - In this Thursday, Dec. 17, 2020 file image taken from video and provided by House Television, Kathe Sackler, a member of the family that owns Purdue Pharma testifies via video to a House Oversight Committee hearing in Washington. A federal appeals panel is scheduled to hear arguments on whether members of the Sackler family can be granted protection from lawsuits as part of a bankruptcy settlement for the company they own, OxyContin maker Purdue Pharma. If the company doesn’t get what it wants, it could have to fight off thousands of individual lawsuits. (House Television via AP, File) FILE — In this image from House Television, David Sackler, a member of the family that owns Purdue Pharma, testifies via video to a House Oversight Committee hearing, Dec. 17, 2020. A federal appeals panel is scheduled to hear arguments on whether members of the Sackler family can be granted protection from lawsuits as part of a bankruptcy settlement for the company they own, OxyContin maker Purdue Pharma. If the company doesn’t get what it wants, it could have to fight off thousands of individual lawsuits. (House Television via AP, File) FILE - Nicholas Rivers of Maine, holds a sign that reads DOJ Hammer the Sacklers" during a protest with advocates for opioid victims outside the Department of Justice, Friday, Dec. 3, 2021, in Washington. A federal appeals panel is scheduled to hear arguments on whether members of the Sackler family can be granted protection from lawsuits as part of a bankruptcy settlement for the company they own, OxyContin maker Purdue Pharma. If the company doesn’t get what it wants, it could have to fight off thousands of individual lawsuits. (AP Photo/Carolyn Kaster, File)
Appeals court to consider paving way for Purdue Pharma deal